Cedars-Sinai Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Cedars-Sinai Medical Center sits in the top decile of US sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count).
Cedars-Sinai Medical Center: 339 sponsored US clinical trials, 70 recruiting.
Cedars-Sinai Medical Center sponsors 339 registered US clinical trials on ClinicalTrials.gov, 70 of them currently recruiting, and 180 completed. 42 of these trials are in Phase 3-4 (later-stage) and 83 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bladder Cancer, with 6 trials.
Top-decile sponsor footprint
Cedars-Sinai Medical Center ranks in the top decile of sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
180 of 230 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
339 total, page 5 of 7
Brief Inpatient Psychotherapy for Depression
NCT03091582
Effects of Carbon Monoxide Breathing on Blood Vessel Function
NCT03067701
Effect of a Warming Mattress on Perioperative Hypothermia Following Cesarean Delivery
NCT02837913
My Nutritional Health App Testing
NCT03052452
Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes
NCT02530216
Safety and Efficacy of Liraglutide in Parkinson's Disease
NCT02953665
CNS10-NPC-GDNF for the Treatment of ALS
NCT02943850
Personalized Cancer Care at Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute
NCT03098576
AbStats: Assessing Post-Prandial Intestinal Event Rates in Healthy Individuals
NCT02906293
Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring
NCT03064360
Emerging From the Haze for Gynecologic Cancer Survivors
NCT02918461
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
NCT03018366
FOCUS:Families OverComing Under Stress
NCT02992405
LOL: It's All Improv After Cancer! The Impact of Improvisational Comedy on Well-Being Among Patients With Cancer
NCT02892006
Immersive Virtual Reality Intervention for Non-Opioid Pain Management: A Randomized Controlled Trial
NCT02887989
A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast Cancer
NCT02707510
Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis
NCT02735746
STOP Heart Disease in Breast Cancer Survivors Trial
NCT02674204
Using Fitbit to Monitor Ambulation in Patients After Surgery.
NCT02741895
The Use of Airway Clearance Devices in ALS
NCT02682030
A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
NCT02608684
Vascular Aging in Flight Attendants With Occupational Secondhand Smoke Exposure
NCT02795624
Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer
NCT02659358
Rates of Middle Meatus Synechiae Formation Post Endoscopic Sinus Surgery
NCT02627794
18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques
NCT02607748
Does Breastfeeding Lower Blood Pressure in Postpartum Hypertensive Patients
NCT02574494
Dried Blood Spot- Statin Pilot Study
NCT02402803
E-Cigarette Aerosol, Conventional Cigarette Smoke, and Myocardial Perfusion
NCT02612701
Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal
NCT02534376
Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment
NCT02360917
Virtual Reality in Inpatients
NCT02456987
Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation
NCT02426684
Sodium Nitrate for Muscular Dystrophy
NCT02434627
Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure Study
NCT02321618
Effects of Hookah (Waterpipe) Smoking on Blood Vessel Function
NCT03616002
Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study
NCT02296632
Effects of Nicotine-Free Hookah Smoking on Blood Flow to the Heart, Muscle and Skin
NCT02310373
Use of Post Operative Loperamide in Colorectal Patients After Diverting Ileostomies
NCT02263365
Noninvasive Measurement of Sympathetic Nerve Activity in Healthy Volunteers
NCT02264262
C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
NCT02134314
Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth
NCT02251483
Cognitive Motor Therapy Applications Using Videogame Platform
NCT02256007
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
NCT02436057
3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery
NCT02163408
Oral Nifedipine Versus Oral Labetalol
NCT02168309
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
NCT02010606
Impact of Pharmacist Post-discharge Phone Calls on Hospital Readmission and Patient Medication Literacy and Adherence
NCT02031406
Efficacy of Propofol or Midazolam Compare to Placebo for Preoperative Medication
NCT01976845
The Effect of Coffee Consumption in Enhancing Recovery of Bowel Function Following Colorectal Surgery.
NCT02639728
Default BP Medication Intensification
NCT01994408
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 43 |
| Phase 2 | 40 |
| Phase 3 | 9 |
| Phase 4 | 33 |
What is open in the Cedars-Sinai Medical Center pipeline
70 recruiting of 339 indexed (21% open); 180 completed (53%).
Phase mix: 42 late (III/IV) vs 83 early (I/II) (early-phase heavy).
Top condition: Bladder Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cedars-Sinai Medical Center: open-pipeline peers nationwide
Peers matched on 339 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Cedars-Sinai Medical Center sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 339 trials (± recruiting share)
- National Institutes of Health Clinical Center (CC) · 338 trials · 7% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
- National Institute of Mental Health (NIMH) · 343 trials · 12% recruiting
Sponsors near 21% open enrollment (± trial volume)
- University of Colorado, Denver · 21% recruiting · 1,283 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this Cedars-Sinai Medical Center page
339 registered trials is a research-attention snapshot, not an endorsement of Cedars-Sinai Medical Center or any single study.
- 70 of Cedars-Sinai Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bladder Cancer is the condition Cedars-Sinai Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bladder Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Cedars-Sinai Medical Center pipeline card: 339 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.